(Q39524792)

12 September 2017

LDL Lowering After Acute Coronary Syndrome: Is Lower Better? (English)

1 reference

12 September 2017

acute coronary syndrome

1 reference

1

0 references

Vera Bittner

series ordinal

2

0 references

publication date

1 February 2013

1 reference

Current treatment options in cardiovascular medicine

12 September 2017

1 reference

12 September 2017

15

1 reference

12 September 2017

1

1 reference

12 September 2017

33-40

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-012-0221-6

12 September 2017

0 references

cites work

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Healthy men should not take statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infec

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

The safety of statins in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

The controversies of statin therapy: weighing the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Antisense oligonucleotides for the treatment of dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-012-0221-6

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

21 January 2018

1 reference

12 December 2020

Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol

1 reference

12 December 2020

Rapid changes in plaque composition and morphology after intensive lipid lowering therapy: study with serial coronary CT angiography.

1 reference

12 December 2020

Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden.

1 reference

12 December 2020

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

Statins for the primary prevention of cardiovascular disease

1 reference

12 December 2020

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

12 December 2020

Plaque regression and progenitor cell mobilization with intensive lipid elimination regimen (PREMIER) trial design

1 reference

12 December 2020

Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study)

1 reference

12 December 2020

10.1007/S11936-012-0221-6

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

23129439